L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: A double-blind, randomized, placebo-controlled trial

The incidence of severe mucositis in the oral cavity, pharynx and larynx is high among patients with head and neck cancer (HNC) receiving chemoradiotherapy (CRT), resulting in significant pain and impairment of quality of life. The present study investigated whether L-glutamine (glutamine) decreases the severity of mucositis in the oral cavity, pharynx and larynx induced by CRT. This double-blind, randomized, placebo-controlled trial included 40 untreated patients with squamous cell carcinoma of the nasopharynx, oropharynx, hypopharynx or larynx. Patients received 66 or 70 Gy of total radiation at the rate of 2 Gy/fraction daily and 5 fractions/week. Cisplatin (20 mg/m2) and docetaxel (10 mg/m2) were intravenously co-administered once a week for 6 weeks. Patients were randomized to orally receive either glutamine (group G) or placebo (group P) at a dose of 10 g 3 times a day throughout the CRT course. Mucositis was assessed using the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0. The primary end point was mucositis severity. Mucositis developed in all patients. A maximal mucositis grade of G4 was observed in 0 and 25% group G and P patients, respectively, while that of G2 was observed in 10 and 0% group G and P patients, respectively (p=0.023). Glutamine significantly decreased the maximal mucositis grade (group G, 2.9±0.3; group P, 3.3±0.4; p=0.005) and pain score at weeks 4, 5 and 6. Glutamine significantly decreased mucositis severity in the oral cavity, pharynx and larynx induced by CRT in patients with HNC.

[1]  Q. Le,et al.  Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Z. Gulbaş,et al.  Role of glutamine administration on cellular immunity after total parenteral nutrition enriched with glutamine in patients with systemic inflammatory response syndrome. , 2010, Journal of critical care.

[3]  M. Fukuzawa,et al.  Cisplatin upregulates glutamine transport in human intestinal epithelial cells: the protective mechanism of glutamine on intestinal mucosa after chemotherapy. , 2010, JPEN. Journal of parenteral and enteral nutrition.

[4]  C. Onal,et al.  Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters. , 2009, Lung cancer.

[5]  D. Rosenthal,et al.  Strategies for managing radiation-induced mucositis in head and neck cancer. , 2009, Seminars in radiation oncology.

[6]  A. Margulies,et al.  Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. , 2008, European journal of cancer.

[7]  R. Ribeiro,et al.  Glutamine and alanyl-glutamine accelerate the recovery from 5-fluorouracil-induced experimental oral mucositis in hamster , 2007, Cancer Chemotherapy and Pharmacology.

[8]  D. McGuire,et al.  Clinical Practice Guidelines for the Prevention and Treatment of Mucositis , 2007 .

[9]  L. Cerchietti,et al.  Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. , 2006, International journal of radiation oncology, biology, physics.

[10]  P. Warde,et al.  Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules. , 2006, International journal of radiation oncology, biology, physics.

[11]  D. Alpers Glutamine: do the data support the cause for glutamine supplementation in humans? , 2006, Gastroenterology.

[12]  J. Garvin,et al.  A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study , 2005, Bone Marrow Transplantation.

[13]  R. Curi,et al.  Molecular mechanisms of glutamine action , 2005, Journal of cellular physiology.

[14]  A. Naber,et al.  A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients , 2005, Supportive Care in Cancer.

[15]  J. Horáček,et al.  A randomized, double blind comparative study of prophylactic parenteral nutritional support with or without glutamine in autologous stem cell transplantation for hematological malignancies -- three years' follow-up. , 2005, Neoplasma.

[16]  L. Elting,et al.  Perspectives on cancer therapy‐induced mucosal injury , 2004, Cancer.

[17]  P. Chiusolo,et al.  Glutamine parenteral supplementation in stem cell transplant , 2004, Bone Marrow Transplantation.

[18]  P. Wischmeyer,et al.  Prevention of chemotherapy and radiation toxicity with glutamine. , 2003, Cancer treatment reviews.

[19]  W. Walker,et al.  Protective nutrients and functional foods for the gastrointestinal tract. , 2002, The American journal of clinical nutrition.

[20]  D. Burrin,et al.  Glutamine and the bowel. , 2001, The Journal of nutrition.

[21]  S. Pignata,et al.  Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial , 2001, Gut.

[22]  R. Negrin,et al.  Effect of oral glutamine supplementation during bone marrow transplantation. , 2000, JPEN. Journal of parenteral and enteral nutrition.

[23]  F. Fang,et al.  Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial. , 2000, International journal of radiation oncology, biology, physics.

[24]  A. Trotti,et al.  Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer. , 1999, Journal of the National Cancer Institute.

[25]  P. Anderson,et al.  Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy , 1998, Cancer.

[26]  P. Anderson,et al.  Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. , 1996, The Journal of laboratory and clinical medicine.

[27]  J. Monboisse,et al.  Glutamine increases collagen gene transcription in cultured human fibroblasts. , 1995, Biochimica et biophysica acta.

[28]  M. Elia,et al.  A pilot study of oral glutamine supplementation in patients receiving bone marrow transplants. , 1995, Clinical nutrition.

[29]  H. Sauerwein,et al.  Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy‐induced toxicity , 1994, Cancer.

[30]  Sarah E. Jebb,et al.  5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation. , 1994, British Journal of Cancer.

[31]  P. R. Schloerb,et al.  Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study) , 1993, JPEN. Journal of parenteral and enteral nutrition.

[32]  T. Ziegler,et al.  Patients receiving glutamine-supplemented intravenous feedings report an improvement in mood. , 1993, JPEN. Journal of parenteral and enteral nutrition.

[33]  T. Ziegler,et al.  Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. , 1992, Annals of internal medicine.

[34]  E. Aoys,et al.  The effect of glutamine-enriched TPN on gut immune cellularity. , 1992, The Journal of surgical research.

[35]  J. M. Lacey,et al.  Is glutamine a conditionally essential amino acid? , 2009, Nutrition reviews.

[36]  R. Smith,et al.  Glutamine metabolism and its physiologic importance. , 1990, JPEN. Journal of parenteral and enteral nutrition.

[37]  J. Monboisse,et al.  Effects of preformed proline and proline amino acid precursors (including glutamine) on collagen synthesis in human fibroblast cultures. , 1987, Biochimica et biophysica acta.

[38]  K. Takeuchi,et al.  Inhibitory effects of L‐glutamine on the aspirin‐induced gastric lesions in the rat , 1974, The Journal of pharmacy and pharmacology.